Homocarnosine is an endogenous dipeptide distributed in cerebral regions and cerebrospinal fluid.
CAT No: R1914
CAS No: 3650-73-5
Synonyms/Alias: Homocarnosine;L-Homocarnosine;3650-73-5;gamma-Aminobutyryl-L-histidine;(S)-2-(4-Aminobutanamido)-3-(1H-imidazol-4-yl)propanoic acid;gamma-Aminobutyrylhistidine;N-(4-Aminobutyryl)-L-histidine;L-Homocarnosine free base;Histidine, N-(4-aminobutyryl)-, L-;(4-aminobutanoyl)-L-histidine;CHEBI:85981;(2S)-2-(4-aminobutanamido)-3-(1H-imidazol-4-yl)propanoic acid;(2S)-2-(4-aminobutanoylamino)-3-(1H-imidazol-5-yl)propanoic acid;gamma-Aminobutyryl histidine;M8L4BH36SC;.gamma.-Aminobutyrylhistidine;NSC-92522;(S)-homocarnosine;(2S)-homocarnosine;gamma-aminobutyryl-L-His;gamma-aminobutyrilhistidine;g-Aminobutyryl-L-histidine;SCHEMBL541261;N-(4-aminobutyryl)-Histidine;CHEMBL243618;N-(4-Aminobutanoyl)histidine #;N-(4-aminobutanoyl)-L-histidine;CCLQKVKJOGVQLU-QMMMGPOBSA-N;N-(4-Amino-1-oxobutyryl)histidine;N-(4-aminobutanoyl)-(S)-histidine;AKOS010421285;AKOS040752034;N(alpha)-(4-aminobutyryl)-L-histidine;DB-188427;HY-114883;CS-0064557;N-(4-AMINO-1-OXOBUTYL)-L-HISTIDINE;C00884;EN300-172451;Q27158831;
Chemical Name: (2S)-2-(4-aminobutanoylamino)-3-(1H-imidazol-5-yl)propanoic acid
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C10H16N4O3 |
M.W/Mr. | 240.26 |
Sequence | One Letter Code:XH Three Letter Code:deamino-Dab-His-OH |
Appearance | Solid powder |
Long-term Storage Conditions | Soluble in DMSO |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
InChI | InChI=1S/C10H16N4O3/c11-3-1-2-9(15)14-8(10(16)17)4-7-5-12-6-13-7/h5-6,8H,1-4,11H2,(H,12,13)(H,14,15)(H,16,17)/t8-/m0/s1 |
InChI Key | CCLQKVKJOGVQLU-QMMMGPOBSA-N |
Canonical SMILES | C1=C(NC=N1)CC(C(=O)O)NC(=O)CCCN |
Isomeric SMILES | C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)CCCN |
2. The spatiotemporal control of signalling and trafficking of the GLP-1R
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.